As of June 30, 2026, Judges Scientific plc carries a market capitalization of 349.69M, placing it among publicly traded companies globally. Its enterprise value stands at 405.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 349.69M |
| Enterprise Value | 405.64M |
Judges Scientific plc's next confirmed earnings release is scheduled for March 24, 2027.
| Earnings Date | 3/24/2027 |
As of June 30, 2026, Judges Scientific plc has 6.66M shares outstanding.
| Shares Outstanding | 6.66M |
These figures are as of June 30, 2026.
| PB Ratio | 3.62 |
| P/TBV Ratio | 86.07 |
As of June 30, 2026, Judges Scientific plc maintains a current ratio of 2.62, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.62 |
| Quick Ratio | 0.60 |
| Debt / Equity | 76.68 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 791.00 |
As of the close on October 7, 2026, Judges Scientific plc's stock has declined approximately 42.29% over the past 52 weeks. The 50-day moving average sits at 44.61, while the 200-day moving average is 50.32.
| 52-Week Price Change | -42.29% |
| 50-Day Moving Average | 44.61 |
| 200-Day Moving Average | 50.32 |
As of June 30, 2026, Judges Scientific plc holds 18.11M in cash and equivalents against 74.06M in total debt, resulting in a net debt position of 49.91M. Total book value stands at 96.58M, with working capital of 48.64M providing operational flexibility.
| Cash & Cash Equivalents | 18.11M |
| Total Debt | 74.06M |
| Net Debt | 49.91M |
| Equity (Book Value) | 96.58M |
| Book Value Per Share | 14.50 |
| Working Capital | 48.64M |
Already premium?